Des (1-3) IGF Bio-Peptide





Des (1-3) IGF 1mg/vial ***New

Des (1-3) IGF

is a polypeptide that stimulates the growth and differentiation of various types of cells, e.g. muscles, bones, cartilage. DES(1-3)IGF-1 is a variant of IGF-1 in which the Gly-Pro-Glu tripeptide has been cut off from the N end of the peptide, which significantly reduces the ability of the peptide to bind to IGF-binding protein (IGFBPs), thanks to which it is present in the bloodstream. more unbound bioactive peptide. It is obtained from beef protein hydrolyzate, human brain cells and pig uterus tissues. It has approximately 10x greater potential to stimulate cell hypertrophy and differentiation than regular. The peptide was developed for diseases involving severe catabolism and for the treatment of inflammatory bowel diseases. As a result of a number of metabolic diseases, the level of IGF-1 may be reduced – then the administration of IGF-1 reduces the risk associated with the above-mentioned diseases. diseases, 


• Building lean muscle mass
• Relieving the symptoms of inflammatory bowel diseases. 
• Regeneration
• Increased appetite
• Improved sleep quality
• Regeneration of joints, tendons, bones
• Improved skin quality
• Accelerated healing of injuries and micro-damages •
Treatment of diabetic retinopathy
• Neurocognitive effect
• Supportive in the treatment of Azheimer’s disease 
• stimulating the growth and metabolism of epiphyseal cartilages – growth of the skeleton, 
• growth of the body and organs, action 
• inhibits glucose production in the liver, stimulates peripheral glucose consumption and inhibits insulin secretion; increases bone density


The peptide has a short half-life, so it must be administered several times a day. The daily dose is 50-150 mcg – it should be divided into several portions during the day. Can be administered subcutaneously. It can be used topically in a given muscle group whose growth and hypertrophy we want to stimulate – then remember to administer it to the muscles on the right and left side to achieve bilateral symmetrical growth. The minimum cycle length is 2-12 weeks, depending on the IGF-1 level 
. , obtaining the desired effects and the occurrence of possible side effects. 


• risk of hypoglycemia (low sugar level) – at the beginning it is worth starting with smaller doses and controlling the sugar level. Particularly important for people who take metformin, insulin and other hypoglycemic drugs!!!
• water retention
• increased appetite
• enlargement of organs with long-term use without breaks
• neoplastic processes resulting from multi-month cycles – IGF-1 levels should be monitored 
• numbness in the hands – carpal tunnel syndrome

When using the peptide, it is worth checking the fasting glucose and insulin levels periodically; it is advisable to purchase a glucometer. Additionally, it is worth checking blood pressure values.


Related products